RAD21 regulation of the enhancer–promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancer

Rui Gou, Xiaohong Chang, Hongyan Cheng, Xue Ye, Ouxuan Liu, Yuexin Hu, Bei Lin, Xiaoping Li · 2026

Read RAD21 regulation of the enhancer–promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancer by Rui Gou, Xiaohong Chang, Hongyan Cheng, Xue Ye, Ouxuan Liu, Yuexin Hu, Bei Lin, Xiaoping Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471449.txt.

Description

Gou and colleagues investigated why ovarian cancers stop responding to PARP inhibitors, drugs that block a DNA-repair enzyme, focusing on how the drug reshapes chromosome folding. Their 2026 study built a genome-wide contact map of cells treated with olaparib and bred an olaparib-resistant ovarian cancer cell line for comparison.

The team traced resistance to RAD21, a cohesin protein that holds chromosome loops together, which kept the repair gene RAD51 switched on through an enhancer loop. High RAD21 expression in patients was significantly associated with shorter overall and progression-free survival. About half of high-grade serous ovarian cancers carry inherited faults in repair genes such as BRCA1 and BRCA2, the group notes, making resistance mechanisms like this one a central clinical problem.

Catalog record

CREATORRui Gou, Xiaohong Chang, Hongyan Cheng, Xue Ye, Ouxuan Liu, Yuexin Hu, Bei Lin, Xiaoping Li
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13471449

Browse the full library · About the Tower of Babel